Biomarkers such as glial fibrillary acidic protein (GFAP) and S100 calcium-binding protein B (S100B) may help differentiate ischemic from hemorrhagic stroke, but their clinical application remains limited [85,86]. This evidence concerns the gene GFAP and hemorrhagic stroke.